APO Research
Talk to an analyst

APO RESEARCH · REPORT

Colchicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Colchicine Market Outlook and Growth Opportunities 2026

22 December 2025203 pages

Choose your research edition.

Industry ResearchColchicine Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Colchicine Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Colchicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Colchicine Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Colchicine Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Colchicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Colchicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Colchicine market include Yunnan Plant Medicine, Xishuangbanna Pharmaceutical, Takeda Pharmaceuticals, Tonghua Limin, Kunming Pharmaceutical, Beijing Jialin Pharmaceutical, Yunnan Shan State, Wockhardt and West-Ward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Colchicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Colchicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Colchicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Colchicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Colchicine Segment by Company

Yunnan Plant Medicine

Xishuangbanna Pharmaceutical

Takeda Pharmaceuticals

Tonghua Limin

Kunming Pharmaceutical

Beijing Jialin Pharmaceutical

Yunnan Shan State

Wockhardt

West-Ward

Rhea Pharmaceutical

Prasco

Odan Laboratories

Medinova

Hikma

Guangdong Pedi

Excellium Pharmaceutical

Cipla

Colchicine Segment by Type

Tablet

Oral Solution

Colchicine Segment by Application

Acute Gout

Chronic Gout

Other Conditions

Colchicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Colchicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Colchicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Colchicine significant trends, drivers, influence factors in global and regions.

6. To analyze Colchicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colchicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colchicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colchicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Colchicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Colchicine industry.

Chapter 3: Detailed analysis of Colchicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Colchicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Colchicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Colchicine Industry Trends Table 2. Colchicine Industry Drivers Table 3. Colchicine Industry Opportunities and Challenges Table 4. Colchicine Industry Restraints Table 5. Global Colchicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Colchicine Revenue Share by Company (2021-2026) Table 7. Global Colchicine Sales Volume by Company (tons) & (2021-2026) Table 8. Global Colchicine Sales Volume Share by Company (2021-2026) Table 9. Global Colchicine Average Price (US$/kg) of Company (2021-2026) Table 10. Global Colchicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Colchicine Key Company Manufacturing Base & Headquarters Table 12. Global Colchicine Company, Product Type & Application Table 13. Global Colchicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Colchicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Oral Solution Table 19. Global Colchicine Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Colchicine Sales Volume by Type (2021-2026) & (tons) Table 21. Global Colchicine Sales Volume by Type (2027-2032) & (tons) Table 22. Global Colchicine Sales Volume Share by Type (2021-2026) Table 23. Global Colchicine Sales Volume Share by Type (2027-2032) Table 24. Global Colchicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Colchicine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Colchicine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Colchicine Sales Value Share by Type (2021-2026) Table 28. Global Colchicine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Acute Gout Table 30. Significant Companies of Chronic Gout Table 31. Significant Companies of Other Conditions Table 32. Global Colchicine Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 33. Global Colchicine Sales Volume by Application (2021-2026) & (tons) Table 34. Global Colchicine Sales Volume by Application (2027-2032) & (tons) Table 35. Global Colchicine Sales Volume Share by Application (2021-2026) Table 36. Global Colchicine Sales Volume Share by Application (2027-2032) Table 37. Global Colchicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Colchicine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Colchicine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Colchicine Sales Value Share by Application (2021-2026) Table 41. Global Colchicine Sales Value Share by Application (2027-2032) Table 42. Global Colchicine Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 43. Global Colchicine Sales by Region (2021-2026) & (tons) Table 44. Global Colchicine Sales Market Share by Region (2021-2026) Table 45. Global Colchicine Sales by Region (2027-2032) & (tons) Table 46. Global Colchicine Sales Market Share by Region (2027-2032) Table 47. Global Colchicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Colchicine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Colchicine Sales Value Share by Region (2021-2026) Table 50. Global Colchicine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Colchicine Sales Value Share by Region (2027-2032) Table 52. Global Colchicine Market Average Price (US$/kg) by Region (2021-2026) Table 53. Global Colchicine Market Average Price (US$/kg) by Region (2027-2032) Table 54. Global Colchicine Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 55. Global Colchicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Colchicine Sales by Country (2021-2026) & (tons) Table 57. Global Colchicine Sales Market Share by Country (2021-2026) Table 58. Global Colchicine Sales by Country (2027-2032) & (tons) Table 59. Global Colchicine Sales Market Share by Country (2027-2032) Table 60. Global Colchicine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Colchicine Sales Value Market Share by Country (2021-2026) Table 62. Global Colchicine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Colchicine Sales Value Market Share by Country (2027-2032) Table 64. Yunnan Plant Medicine Company Information Table 65. Yunnan Plant Medicine Business Overview Table 66. Yunnan Plant Medicine Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Yunnan Plant Medicine Colchicine Product Portfolio Table 68. Yunnan Plant Medicine Recent Development Table 69. Xishuangbanna Pharmaceutical Company Information Table 70. Xishuangbanna Pharmaceutical Business Overview Table 71. Xishuangbanna Pharmaceutical Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Xishuangbanna Pharmaceutical Colchicine Product Portfolio Table 73. Xishuangbanna Pharmaceutical Recent Development Table 74. Takeda Pharmaceuticals Company Information Table 75. Takeda Pharmaceuticals Business Overview Table 76. Takeda Pharmaceuticals Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Takeda Pharmaceuticals Colchicine Product Portfolio Table 78. Takeda Pharmaceuticals Recent Development Table 79. Tonghua Limin Company Information Table 80. Tonghua Limin Business Overview Table 81. Tonghua Limin Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Tonghua Limin Colchicine Product Portfolio Table 83. Tonghua Limin Recent Development Table 84. Kunming Pharmaceutical Company Information Table 85. Kunming Pharmaceutical Business Overview Table 86. Kunming Pharmaceutical Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. Kunming Pharmaceutical Colchicine Product Portfolio Table 88. Kunming Pharmaceutical Recent Development Table 89. Beijing Jialin Pharmaceutical Company Information Table 90. Beijing Jialin Pharmaceutical Business Overview Table 91. Beijing Jialin Pharmaceutical Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Beijing Jialin Pharmaceutical Colchicine Product Portfolio Table 93. Beijing Jialin Pharmaceutical Recent Development Table 94. Yunnan Shan State Company Information Table 95. Yunnan Shan State Business Overview Table 96. Yunnan Shan State Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Yunnan Shan State Colchicine Product Portfolio Table 98. Yunnan Shan State Recent Development Table 99. Wockhardt Company Information Table 100. Wockhardt Business Overview Table 101. Wockhardt Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Wockhardt Colchicine Product Portfolio Table 103. Wockhardt Recent Development Table 104. West-Ward Company Information Table 105. West-Ward Business Overview Table 106. West-Ward Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. West-Ward Colchicine Product Portfolio Table 108. West-Ward Recent Development Table 109. Rhea Pharmaceutical Company Information Table 110. Rhea Pharmaceutical Business Overview Table 111. Rhea Pharmaceutical Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 112. Rhea Pharmaceutical Colchicine Product Portfolio Table 113. Rhea Pharmaceutical Recent Development Table 114. Prasco Company Information Table 115. Prasco Business Overview Table 116. Prasco Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 117. Prasco Colchicine Product Portfolio Table 118. Prasco Recent Development Table 119. Odan Laboratories Company Information Table 120. Odan Laboratories Business Overview Table 121. Odan Laboratories Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 122. Odan Laboratories Colchicine Product Portfolio Table 123. Odan Laboratories Recent Development Table 124. Medinova Company Information Table 125. Medinova Business Overview Table 126. Medinova Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 127. Medinova Colchicine Product Portfolio Table 128. Medinova Recent Development Table 129. Hikma Company Information Table 130. Hikma Business Overview Table 131. Hikma Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 132. Hikma Colchicine Product Portfolio Table 133. Hikma Recent Development Table 134. Guangdong Pedi Company Information Table 135. Guangdong Pedi Business Overview Table 136. Guangdong Pedi Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 137. Guangdong Pedi Colchicine Product Portfolio Table 138. Guangdong Pedi Recent Development Table 139. Excellium Pharmaceutical Company Information Table 140. Excellium Pharmaceutical Business Overview Table 141. Excellium Pharmaceutical Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 142. Excellium Pharmaceutical Colchicine Product Portfolio Table 143. Excellium Pharmaceutical Recent Development Table 144. Cipla Company Information Table 145. Cipla Business Overview Table 146. Cipla Colchicine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 147. Cipla Colchicine Product Portfolio Table 148. Cipla Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Colchicine Distributors List Table 152. Colchicine Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Colchicine Product Image Figure 2. Global Colchicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colchicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Colchicine Sales (2021-2032) & (tons) Figure 5. Global Colchicine Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Colchicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Oral Solution Image Figure 11. Global Colchicine Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Colchicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Colchicine Sales Volume Share by Type (2021-2032) Figure 14. Global Colchicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Colchicine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Colchicine Sales Value Share by Type (2021-2032) Figure 17. Acute Gout Image Figure 18. Chronic Gout Image Figure 19. Other Conditions Image Figure 20. Global Colchicine Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 21. Global Colchicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Colchicine Sales Volume Share by Application (2021-2032) Figure 23. Global Colchicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Colchicine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Colchicine Sales Value Share by Application (2021-2032) Figure 26. Global Colchicine Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 27. Global Colchicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Colchicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Colchicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Colchicine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Colchicine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Colchicine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Colchicine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Colchicine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Colchicine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Colchicine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Colchicine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Colchicine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Colchicine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Colchicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Colchicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Colchicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Colchicine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Colchicine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Acute Gout
  • Chronic Gout
  • Other Conditions
Companies covered
  • Yunnan Plant Medicine
  • Xishuangbanna Pharmaceutical
  • Takeda Pharmaceuticals
  • Tonghua Limin
  • Kunming Pharmaceutical
  • Beijing Jialin Pharmaceutical
  • Yunnan Shan State
  • Wockhardt
  • West-Ward
  • Rhea Pharmaceutical
  • Prasco
  • Odan Laboratories
  • Medinova
  • Hikma
  • Guangdong Pedi
  • Excellium Pharmaceutical
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Colchicine Sales Value (2021-2032)
  4. 1.2.2 Global Colchicine Sales Volume (2021-2032)
  5. 1.2.3 Global Colchicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Colchicine Market Dynamics
  1. 2.1 Colchicine Industry Trends
  2. 2.2 Colchicine Industry Drivers
  3. 2.3 Colchicine Industry Opportunities and Challenges
  4. 2.4 Colchicine Industry Restraints
3 Colchicine Market by Company
  1. 3.1 Global Colchicine Company Revenue Ranking in 2025
  2. 3.2 Global Colchicine Revenue by Company (2021-2026)
  3. 3.3 Global Colchicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Colchicine Average Price by Company (2021-2026)
  5. 3.5 Global Colchicine Company Ranking (2024-2026)
  6. 3.6 Global Colchicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Colchicine Company Product Type and Application
  8. 3.8 Global Colchicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Colchicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Colchicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Colchicine Market by Type
  1. 4.1 Colchicine Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral Solution
  4. 4.2 Global Colchicine Sales Volume by Type
  5. 4.2.1 Global Colchicine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Colchicine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Colchicine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Colchicine Sales Value by Type
  9. 4.3.1 Global Colchicine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Colchicine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Colchicine Sales Value Share by Type (2021-2032)
5 Colchicine Market by Application
  1. 5.1 Colchicine Application Introduction
  2. 5.1.1 Acute Gout
  3. 5.1.2 Chronic Gout
  4. 5.1.3 Other Conditions
  5. 5.2 Global Colchicine Sales Volume by Application
  6. 5.2.1 Global Colchicine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Colchicine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Colchicine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Colchicine Sales Value by Application
  10. 5.3.1 Global Colchicine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Colchicine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Colchicine Sales Value Share by Application (2021-2032)
6 Colchicine Regional Sales and Value Analysis
  1. 6.1 Global Colchicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Colchicine Sales by Region (2021-2032)
  3. 6.2.1 Global Colchicine Sales by Region: 2021-2026
  4. 6.2.2 Global Colchicine Sales by Region (2027-2032)
  5. 6.3 Global Colchicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Colchicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Colchicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Colchicine Sales Value by Region (2027-2032)
  9. 6.5 Global Colchicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Colchicine Sales Value (2021-2032)
  12. 6.6.2 North America Colchicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Colchicine Sales Value (2021-2032)
  15. 6.7.2 Europe Colchicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Colchicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Colchicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Colchicine Sales Value (2021-2032)
  21. 6.9.2 South America Colchicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Colchicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Colchicine Sales Value Share by Country, 2025 VS 2032
7 Colchicine Country-level Sales and Value Analysis
  1. 7.1 Global Colchicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Colchicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Colchicine Sales by Country (2021-2032)
  4. 7.3.1 Global Colchicine Sales by Country (2021-2026)
  5. 7.3.2 Global Colchicine Sales by Country (2027-2032)
  6. 7.4 Global Colchicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Colchicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Colchicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Colchicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Colchicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Colchicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Colchicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Colchicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Colchicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Colchicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Colchicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Colchicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Colchicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Colchicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Colchicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Colchicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Colchicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Colchicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Colchicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Colchicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Colchicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Colchicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Colchicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Colchicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Colchicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Colchicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Colchicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Colchicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Colchicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Colchicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Colchicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Colchicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Colchicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Colchicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Colchicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Colchicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Colchicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Colchicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Colchicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Colchicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Colchicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Colchicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Colchicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Colchicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Colchicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Colchicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Colchicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Colchicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Colchicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Colchicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Colchicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Colchicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Colchicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Colchicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Colchicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Colchicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Colchicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Colchicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Colchicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Colchicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Colchicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Colchicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Colchicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Colchicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Colchicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Colchicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Colchicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Colchicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Colchicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Colchicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Colchicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Colchicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Colchicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Colchicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Colchicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Colchicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Colchicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Colchicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Colchicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Colchicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Colchicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Colchicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Colchicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Colchicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Colchicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Colchicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Colchicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunnan Plant Medicine
  2. 8.1.1 Yunnan Plant Medicine Company Information
  3. 8.1.2 Yunnan Plant Medicine Business Overview
  4. 8.1.3 Yunnan Plant Medicine Colchicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yunnan Plant Medicine Colchicine Product Portfolio
  6. 8.1.5 Yunnan Plant Medicine Recent Developments
  7. 8.2 Xishuangbanna Pharmaceutical
  8. 8.2.1 Xishuangbanna Pharmaceutical Company Information
  9. 8.2.2 Xishuangbanna Pharmaceutical Business Overview
  10. 8.2.3 Xishuangbanna Pharmaceutical Colchicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xishuangbanna Pharmaceutical Colchicine Product Portfolio
  12. 8.2.5 Xishuangbanna Pharmaceutical Recent Developments
  13. 8.3 Takeda Pharmaceuticals
  14. 8.3.1 Takeda Pharmaceuticals Company Information
  15. 8.3.2 Takeda Pharmaceuticals Business Overview
  16. 8.3.3 Takeda Pharmaceuticals Colchicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Pharmaceuticals Colchicine Product Portfolio
  18. 8.3.5 Takeda Pharmaceuticals Recent Developments
  19. 8.4 Tonghua Limin
  20. 8.4.1 Tonghua Limin Company Information
  21. 8.4.2 Tonghua Limin Business Overview
  22. 8.4.3 Tonghua Limin Colchicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tonghua Limin Colchicine Product Portfolio
  24. 8.4.5 Tonghua Limin Recent Developments
  25. 8.5 Kunming Pharmaceutical
  26. 8.5.1 Kunming Pharmaceutical Company Information
  27. 8.5.2 Kunming Pharmaceutical Business Overview
  28. 8.5.3 Kunming Pharmaceutical Colchicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kunming Pharmaceutical Colchicine Product Portfolio
  30. 8.5.5 Kunming Pharmaceutical Recent Developments
  31. 8.6 Beijing Jialin Pharmaceutical
  32. 8.6.1 Beijing Jialin Pharmaceutical Company Information
  33. 8.6.2 Beijing Jialin Pharmaceutical Business Overview
  34. 8.6.3 Beijing Jialin Pharmaceutical Colchicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Jialin Pharmaceutical Colchicine Product Portfolio
  36. 8.6.5 Beijing Jialin Pharmaceutical Recent Developments
  37. 8.7 Yunnan Shan State
  38. 8.7.1 Yunnan Shan State Company Information
  39. 8.7.2 Yunnan Shan State Business Overview
  40. 8.7.3 Yunnan Shan State Colchicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Yunnan Shan State Colchicine Product Portfolio
  42. 8.7.5 Yunnan Shan State Recent Developments
  43. 8.8 Wockhardt
  44. 8.8.1 Wockhardt Company Information
  45. 8.8.2 Wockhardt Business Overview
  46. 8.8.3 Wockhardt Colchicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Wockhardt Colchicine Product Portfolio
  48. 8.8.5 Wockhardt Recent Developments
  49. 8.9 West-Ward
  50. 8.9.1 West-Ward Company Information
  51. 8.9.2 West-Ward Business Overview
  52. 8.9.3 West-Ward Colchicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 West-Ward Colchicine Product Portfolio
  54. 8.9.5 West-Ward Recent Developments
  55. 8.10 Rhea Pharmaceutical
  56. 8.10.1 Rhea Pharmaceutical Company Information
  57. 8.10.2 Rhea Pharmaceutical Business Overview
  58. 8.10.3 Rhea Pharmaceutical Colchicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Rhea Pharmaceutical Colchicine Product Portfolio
  60. 8.10.5 Rhea Pharmaceutical Recent Developments
  61. 8.11 Prasco
  62. 8.11.1 Prasco Company Information
  63. 8.11.2 Prasco Business Overview
  64. 8.11.3 Prasco Colchicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Prasco Colchicine Product Portfolio
  66. 8.11.5 Prasco Recent Developments
  67. 8.12 Odan Laboratories
  68. 8.12.1 Odan Laboratories Company Information
  69. 8.12.2 Odan Laboratories Business Overview
  70. 8.12.3 Odan Laboratories Colchicine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Odan Laboratories Colchicine Product Portfolio
  72. 8.12.5 Odan Laboratories Recent Developments
  73. 8.13 Medinova
  74. 8.13.1 Medinova Company Information
  75. 8.13.2 Medinova Business Overview
  76. 8.13.3 Medinova Colchicine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Medinova Colchicine Product Portfolio
  78. 8.13.5 Medinova Recent Developments
  79. 8.14 Hikma
  80. 8.14.1 Hikma Company Information
  81. 8.14.2 Hikma Business Overview
  82. 8.14.3 Hikma Colchicine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hikma Colchicine Product Portfolio
  84. 8.14.5 Hikma Recent Developments
  85. 8.15 Guangdong Pedi
  86. 8.15.1 Guangdong Pedi Company Information
  87. 8.15.2 Guangdong Pedi Business Overview
  88. 8.15.3 Guangdong Pedi Colchicine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guangdong Pedi Colchicine Product Portfolio
  90. 8.15.5 Guangdong Pedi Recent Developments
  91. 8.16 Excellium Pharmaceutical
  92. 8.16.1 Excellium Pharmaceutical Company Information
  93. 8.16.2 Excellium Pharmaceutical Business Overview
  94. 8.16.3 Excellium Pharmaceutical Colchicine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Excellium Pharmaceutical Colchicine Product Portfolio
  96. 8.16.5 Excellium Pharmaceutical Recent Developments
  97. 8.17 Cipla
  98. 8.17.1 Cipla Company Information
  99. 8.17.2 Cipla Business Overview
  100. 8.17.3 Cipla Colchicine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Cipla Colchicine Product Portfolio
  102. 8.17.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Colchicine Value Chain Analysis
  2. 9.1.1 Colchicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Colchicine Sales Mode & Process
  6. 9.2 Colchicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Colchicine Distributors
  9. 9.2.3 Colchicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst